UltraSight touts cardiac ultrasound study
Ultrasight is highlighting a study showing that its point-of-care ultrasound (POCUS) AI software can help novice users interpret diagnostic cardiac images. Researchers led by Roberto Lang, MD, of the University of Chicago, assessed the quality of echocardiographic exams performed by inexperienced users guided by Ultrasight’s software and evaluated their suitability for diagnostic interpretation of basic cardiac pathology, as well as quantitative analysis of cardiac chamber and function.“After minimal training with the real-time guidance software, novice users can acquire images of diagnostic quality approaching that of...
Source: AuntMinnie.com Headlines - November 15, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Healthcare Strikes Around the World Challenge Pay and Poor Working Conditions
Millions of cancelled healthcare appointments and lengthy waits for care abound in UK, New Zealand, and in the US Strikes continue on multiple continents as thousands of healthcare workers walk off the job. Doctors, medical laboratory scientists, nurses, phlebotomists and others around the world have taken to the picket lines complaining about low wages, inadequate […]
The post Healthcare Strikes Around the World Challenge Pay and Poor Working Conditions appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - November 13, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Hiring & Human Resources Laboratory Management and Operations Laboratory Resources anatomic pathology Andy Davies BBC BMA bookings British Medical Association clinical laboratory clinical path Source Type: news
CT-based deep learning radiomics may help determine NSCLC treatment
Thursday, November 30 | 11:10 a.m.-11:20 a.m. | R4-SSCH10-2 | Room S405 A CT-based deep-learning radiomics biomarker appears to characterize the level of expression of programmed cell death ligand 1 (PD-L1) in non-small cell lung cancers (NSCLCs), according to study results that will be presented Thursday morning.The findings could help clinicians set treatment for lung cancer patients, since tumors that express 50% or greater levels of PD-L1 tend to respond well to immunotherapy, wrote a team led by Jingshan Gong, MD, of Shenzhen Second People's Hospital in China.The study included 259 patients with pathology-confirmed ...
Source: AuntMinnie.com Headlines - November 13, 2023 Category: Radiology Authors: Kate Madden Yee Tags: 2023 CT Preview Source Type: news
Recombined CEM images effective for depicting palpable breast lesions
When it comes to working up palpable breast abnormalities with contrast-enhanced mammography (CEM), recombined images better depict the lesion than low-energy ones, research published November 8 in Academic Radiology has found.The findings shed light on a condition that, although is most commonly benign, can also can be a common presenting symptom of breast cancer, wrote a team led by Tali Amir, MD, of Memorial Sloan Kettering Cancer Center in New York City."As such, a thorough work-up [of palpable breast lesions] to exclude carcinoma must always be performed," the group noted.CEM is a promising technology for this applica...
Source: AuntMinnie.com Headlines - November 13, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Subspecialties Breast Imaging Source Type: news
Elucid raises $80M in funding round
AI imaging software developer Elucid recently raised $80 million in series C funding, led by Elevage Medical Technologies, with additional participation from industry strategic and existing investors.The company said this funding will help with the expansion of commercialization efforts to provide physicians and patients with critical information to combat heart disease. This round brings the company’s total funding to $121 million since inception. Elucid’s software has 501(k) clearance by the U.S. Food and Drug Administration (FDA) and can characterize arterial plaque, simulating what pathologists would see under a...
Source: AuntMinnie.com Headlines - November 9, 2023 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
INFINITT North America (INA) is excited to share the news of its latest collaboration with Aiforia
INA has collaborated with Aiforia to harness artificial intelligence software for image analysis in pathology. This alliance aims to address staffing shortages and improve patient care standards. INA's digital pathology solution, IDPS, enables seamless integration of whole-slide images... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 8, 2023 Category: Pharmaceuticals Tags: LIC Source Type: news
Might Bacteria be Used to Identify Cancer Cells? Some Researchers Using Synthetic Biology and Genetic Engineering Techniques Say ‘Yes’
Cellular healthcare is an approach that goes beyond clinical laboratory testing to identify the location of specific cancer cells and aid in treatment decisions Advances in synthetic biology and genetic engineering are leading to development of bacterial biosensors that could eventually aid pathologists and clinical laboratories in diagnosis of many types of cancers. One recent […]
The post Might Bacteria be Used to Identify Cancer Cells? Some Researchers Using Synthetic Biology and Genetic Engineering Techniques Say ‘Yes’ appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - November 8, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory Pathology Laboratory Resources Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing Precision Medicine A. baylyi Acinetobacter baylyi anatomic pathology bacterial biosensors CATCH Cellular Assay f Source Type: news
RNA Therapeutics Will'Change Everything' in Epilepsy RNA Therapeutics Will'Change Everything' in Epilepsy
The development of RNA therapeutics for epilepsy will"change everything" because it opens up entirely new druggable targets and address the underlying causes of epilepsy, experts say.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 7, 2023 Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news
The Harrowing Work of Burying Ukraine ’s War Dead
DNIPRO, Ukraine—The number of Ukrainians being killed by Russian invaders has stretched resources at Morgue No. 4 in this eastern city. All but two of a dozen body bags lay on the floor at the rear entrance one recent morning because there weren’t enough gurneys. Forensic pathologist Vitaliy…#dnipro #ukraine #ukrainians #russian #morgueno4 #forensic #vitaliylevchenko (Source: Reuters: Health)
Source: Reuters: Health - November 7, 2023 Category: Consumer Health News Source Type: news
PET shows ApoE4 carriers may benefit from earlier AD treatment
PET imaging has revealed brain pathology linked to faster clinical progression of Alzheimer’s disease in patients with ApoE4 gene variants, according to a study published November 6 in JAMA Neurology.Based on PET scans from patients enrolled in previous studies, researchers found that ApoE4 carriers showed an acceleration of amyloid-mediated tau spreading compared with ApoE4 noncarriers. The study provides evidence that these patients may benefit from earlier treatments, suggested lead author Anna Steward, of Ludwig Maximilian University of Munich, and colleagues.“The timing of therapeutic windows in anti-amyloid thera...
Source: AuntMinnie.com Headlines - November 6, 2023 Category: Radiology Authors: Will Morton Tags: Subspecialties Molecular Imaging Neuroradiology Source Type: news
Volition and VPG Launch Nu.Q ® Vet Cancer Test in UK & amp; Ireland
HENDERSON, Nev., Nov. 6, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, and Veterinary Pathology Group (VPG), a leading high quality diagnostic laboratory, have joined forces to launch the Nu.Q® Vet Cancer Test to... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - November 6, 2023 Category: Pharmaceuticals Tags: PDT PET LIC Source Type: news
Security Breach at 23andMe Leaks Genetic and Personal Information for Thousands, Targets Ashkenazi Jews and Chinese
Federal class action lawsuit looms as genetics company searches for what went wrong; a reminder to clinical laboratories of the importance of protecting patient information Several years ago, security experts warned that biotechnology and genomics company 23andMe, along with other similar genetics companies, would be attacked by hackers. Now those predictions appear to have come […]
The post Security Breach at 23andMe Leaks Genetic and Personal Information for Thousands, Targets Ashkenazi Jews and Chinese appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - November 6, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Compliance, Legal, and Malpractice Laboratory Management and Operations Laboratory Resources Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing 23andMe anatomic pathology Ancestry Anne Wojcicki Ashkenazi Jew Source Type: news
Data Theft at 23andMe Leaks Genetic and Personal Information for Thousands, Targets Ashkenazi Jews and Chinese
Federal class action lawsuit looms as genetics company searches for what went wrong; a reminder to clinical laboratories of the importance of protecting patient information Several years ago, security experts warned that biotechnology and genomics company 23andMe, along with other similar genetics companies, would be attacked by hackers. Now those predictions appear to have come […]
The post Data Theft at 23andMe Leaks Genetic and Personal Information for Thousands, Targets Ashkenazi Jews and Chinese appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - November 6, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Compliance, Legal, and Malpractice Laboratory Management and Operations Laboratory Resources Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing 23andMe anatomic pathology Ancestry Anne Wojcicki Ashkenazi Jew Source Type: news
MRI radiomics show promise for identifying Ki-67 breast cancer
MRI radiomics show a high diagnostic accuracy for predicting Ki-67 expression in breast cancer, researchers have found.
The findings are good news for patients when it comes to assessing disease, as Ki-67 is an effective indicator of tumor aggressiveness, wrote a team led by Peyman Tabnak, MD, of Tabriz University of Medical Sciences in Tabriz, Iran.
"[Accurate] estimation of Ki-67 is essential for both tumor classification and prognosis prediction," the group noted.
Breast cancer is the most common form of cancer among women, and immunohistochemical biomarkers such as ER, PR, and HER2 have long been used to classify it...
Source: AuntMinnie.com Headlines - November 6, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News MRI Breast Imaging Source Type: news
